When Ryan Schlosser received his master's degree this year, he thought of everyone who supported him along the way, especially his care team at the Francis H. Burr Proton Therapy Center at MGHfC, who played a larger role in his success than he ever imagined.
Torunn Yock, MD
Torunn Yock, MD
Professor, Harvard Medical School
Chair, Radiation Oncology Quality Assurance
Departments, Centers, & Programs:
Massachusetts General Hospital
55 Fruit St.
Boston, MA 02114
- MD, Harvard Medical School
- MD, Harvard University School of Public Health
- Residency, Massachusetts General Hospital
American Board Certifications
- Radiation Oncology, American Board of Radiology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Yock is currently the director of Pediatric Radiation Oncology at Massachusetts General Hospital which is the largest pediatric proton program in the world, having treated over 1700 pediatric proton patients. As the primary investigator of 6 prospective proton protocols, her research focuses on quantifying the late effects and Health-Related Quality of Life in pediatric cancer patients treated with radiotherapy. In addition, Dr. Yock is leading a successful multi-site pediatric radiation registry, the Pediatric Proton/Photon Consortium Registry (PPCR), in which over 2600 patients have been enrolled and receives support from NCI, and internal funding and some industry support as well. Dr. Yock's career has focused on measuring health outcomes to further improve upon cure rates and the quality of the survivorship in pediatric cancer patients and applying big data principles to research repositories. Her research has focused on the role of proton radiotherapy in pediatric cancer and both its power to mitigate late effects in our childhood cancer survivors, but also its potential pitfalls.
Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar;17(3):287-98.
Vatner RE, Niemierko A, Misra M, Weyman E, Goebel C, Ebb D, Jones R, Huang M, Mahajan A, Grosshans D, Paulino A, Stanley T, MacDonald SM, Tarbell NJ, Yock TI. Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors. J Clin Oncol. 2018 Oct 1;36(28):2854-2862.
Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 Jun; 18(6): 881-7.
Ladra ML, Szymonifka J, Mahajan A, Friedmann AM, Yeap BY, Goebel C, MacDonald SM, Grosshans D, Rodriguez-Galindo C, Marcus KJ, Tarbell NJ, Yock TI. Preliminary results of a Phase II Trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20;32(33):3762-70.
Kuhlthau K, Pulsifer MB, Yeap BY, Morales DR, Delahaye J, Hill KS, Ebb D, Abram A, MacDonald SM, Tarbell NJ, Yock TI, A prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012 Jun 10;30(17):2079-86. PMID: 22565004
- Patient Story
- Nov | 20 | 2015
Charlie Beecher's family described the first two years of his life as joyously normal until Charlie developed belly pain. When they found out it was cancer, the Beechers brought Charlie to the Francis H. Burr Proton Therapy Center, which helped Charlie return to his normal, happy childhood.
- Patient Story
- Sep | 2 | 2015
When Alex Sheehan was diagnosed with a brain tumor at age 10, staff at the Francis H. Burr Proton Therapy Center helped him simply be a kid during a challenging time.